ITCC-067 Quizartinib
A phase I/II, multi-center, dose-escalating study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of Quizartinib administered in combination with re-induction chemotherapy, and as a single-agent maintenance therapy
Promotor Name : Daiichi Sankyo, Inc
Investigator Name : M. ZWAAN
Trial registered on clinicaltrial.gov : NCT03793478
